Q3 Pharma Earnings Preview: Novo Nordisk, Shire And Teva

 
• By Scrip Team

Pricing pressure and difficulties with market access in competitive classes will be common themes as Teva, Novo Nordisk and Shire report third quarter sales and earnings.

weather forecast. wind sock in the blue sky
Which way is the wind blowing for biopharma? • Source: Shutterstock

More from Earnings

More from Business